- Report
- February 2024
- 70 Pages
France
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Germany
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Malaysia
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 130 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 114 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 112 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 114 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 112 Pages
North America
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Africa, Middle East
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
North America
From €4248EUR$4,750USD£3,693GBP
- Report
- February 2024
- 70 Pages
Europe
From €4248EUR$4,750USD£3,693GBP
- Report
- August 2023
- 70 Pages
Latin America
From €4248EUR$4,750USD£3,693GBP
- Report
- August 2022
- 120 Pages
Global
From €4248EUR$4,750USD£3,693GBP
- Report
- May 2024
- 139 Pages
Global
From €5812EUR$6,499USD£5,053GBP
- Report
- October 2023
- 190 Pages
Global
From €4025EUR$4,500USD£3,499GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3130EUR$3,500USD£2,721GBP
- Report
- December 2024
- 80 Pages
France
From €3130EUR$3,500USD£2,721GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more